At a glance
- Originator Novartis
- Class Antidepressants; Benzamides
- Mechanism of Action Dopamine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 29 Sep 2000 No-Development-Reported for Depression in Canada (PO)
- 29 Sep 2000 No-Development-Reported for Depression in Switzerland (PO)
- 15 Aug 1996 Phase-II clinical trials for Depression in Switzerland (PO)